Global Glyphosate & Organophosphate Intermediates Market Size, Share & Forecast 2026–2033

The world's largest herbicide is priced by the cost of its weaker route

In 2021 IHS Markit valued global glyphosate sales at USD 6.15 billion, 8.32 per cent of the entire crop-protection market and the largest single active ingredient in the world. On our 2025 base year the same molecule is worth USD 2,743.4 million — 55.39 per cent less — and it is being made in greater volume. Tonnage grew while the money halved, and the explanation is not demand.

The price of glyphosate is set by the cash cost of the marginal process route, and the marginal route is the one 46.1 per cent of world capacity sits on. That is not a rhetorical framing; it falls out of two published points in the same year. In March 2025, with glyphosate at roughly RMB 23,000 a tonne, the glycine-method spread was about RMB 9,000. By the end of August, with the price at RMB 27,300 after a 24 per cent run off the year's low, the same spread was RMB 13,600 and gross profit after depreciation and labour was about RMB 3,000 a tonne. The gap between price and spread barely moved — RMB 14,000 then, RMB 13,700 later. Everything above that line is what the route needs in order to exist, and everything below it is what the market was willing to pay. In December, when the price fell back to RMB 23,700, the arithmetic put the industry within about RMB 750 of earning nothing at all.

The market is USD 2,743.4 million in 2025 on 895.7 kilo tons of active-ingredient equivalent, at a blended realisation of USD 3,062.8 a tonne. It reaches USD 4,157.1 million on 1,098.8 kilo tons by 2033, or USD 3,783.3 a tonne — 5.33 per cent in value and 2.59 per cent in volume. The gap between those two rates is the whole forecast. There is no new capacity coming: Beijing placed new glyphosate plants in the restricted category of its 2024 industrial structural adjustment catalogue, and 1,178 kilo tons of world nameplate ran at 76.04 per cent in 2025. Every point of utilisation recovered is 11.78 kilo tons of supply, and that is the only volume the model gives the industry.

This is a report about the chain, and it prices the herbicide. The distinction is deliberate: 0.8123 tonnes of phosphorus trichloride, 0.6509 tonnes of dimethyl phosphite or its PMIDA equivalent, 0.4440 tonnes of glycine and roughly one tonne of chlorine are already inside every tonne of glyphosate sized here. The intermediates are in the number, not beside it. Adding a separate intermediate market on top would count the same phosphorus a second time, and the netting rule is set out in full below.

A tonne of glyphosate, priced from its own cost sheet

Only one company in this market publishes a monthly price path with an auditor's signature on it, and it is the largest Chinese producer. Hubei Xingfa's 2025 annual report reads: supply ample and price drifting down through April to RMB 23,100 a tonne; South American orders arriving from May and the price at RMB 25,000 by the end of June; the export peak and producer maintenance outages taking it to RMB 27,300 at the end of September; and after the overseas buying season closed, RMB 23,700 at the end of December.

At 13 per cent VAT removed and RMB 7.18 to the dollar, the average is USD 3,062.8 a tonne, and that is the realisation applied to every tonne in this report. The shape of the year is more informative than its average. The sell side called the fourth quarter at RMB 30,000 in September; the year closed at RMB 23,700, 21.0 per cent below that forecast. The optimism was not unreasonable — inventories at the multinationals had normalised, the industry had held an anti-involution meeting in Beijing in March, and new supply was running late — and it was still wrong, because what it was forecasting was a spread, and the spread had already been paid.

Two published spread points let the cost structure be reconstructed without a single assumption about glycine or phosphorus prices:

Two readings follow, and both matter commercially. The first is that the conversion cost is stable to within 2 per cent across a 19 per cent move in product price — the fixed and labour content of a glyphosate train is genuinely fixed, which is what makes this a spread business rather than a manufacturing business. The second is that the floor is close. At the December price the glycine route was at or just below the point at which gross profit disappears, and that is the price at which Chinese capacity either cuts rates or waits for the anti-involution consensus to hold.

Inside the tonne, the phosphorus is a bigger number than the profit:

The phosphorus inside a tonne of glyphosate is worth RMB 4,456 — 17.93 per cent of the product price and 1.49 times the entire gross profit the industry earned per tonne in August. The chlorine, at a negative Jiangsu assessment, is a credit of RMB 179, or 0.72 per cent of price. And the comparison that should stop a strategist cold: a tonne of glyphosate sells for 1.0216 times the price of a tonne of yellow phosphorus, and contains 18.32 per cent of one. The chemistry between the furnace and the herbicide — chlorination, methylation, condensation or PMIDA oxidation — is worth 2.2 per cent of the input's unit value. That is the number the whole chain is arguing about.

Two routes, one phosphorus atom

Glyphosate has two commercial routes, and the choice between them is usually presented as a cost question. On the evidence of the coefficients it is not: it is an intermediate question. Both routes carry exactly the same amount of phosphorus into the same molecule, because both deliver one atom of it per molecule of product.

The convergence at 0.8123 is not a coincidence and it is not an approximation: 137.33 divided by 169.07 is the mass ratio of one phosphorus-bearing molecule to another, and both routes feed exactly one phosphorus into exactly one glyphosate. Route choice moves the intermediates, not the phosphorus demand. What it does change is the number, the location and the ownership of the intermediate — the glycine route needs a dimethyl phosphite plant and a glycine plant, the IDA route needs a PMIDA oxidation train and a source of hydrogen cyanide.

The gap between stoichiometry and practice is yield, and it is visible in the PMIDA ratio: 1.3433 tonnes are required by the chemistry and about 1.5 tonnes are consumed in the plant, an implied yield of 89.55 per cent on the oxidation step. That 10 per cent is where process improvement in this industry actually happens, because the phosphorus has already been bought and chlorinated by the time the loss occurs.

One coefficient deserves separate mention because it is routinely misread as a cost line. Methanol is a carrier in the glycine route, not a feedstock. Two moles of methanol per mole of dimethyl phosphite go in — 0.3790 tonnes per tonne of glyphosate — and two moles come back out in the condensation that joins the phosphite to glycine. In a plant with working recovery, net consumption is losses only. Operationally that means methanol shows up in working capital and in the hydrogen chloride balance rather than in the unit cost, and that a methanol outage stops a glycine plant for reasons that have nothing to do with the methanol price.

Fifty-five per cent of the world's tonnage crosses a border

China holds 810 of the world's 1,178 kilo tons of capacity, 68.76 per cent, and exports around four-fifths of what it makes. On the 2025 base that is 492.8 kilo tons of a global 895.7 — 55.02 per cent of world tonnage in one export flow. Chinese domestic consumption is correspondingly small: about 123.2 kilo tons, or 13.75 per cent of the world market, in the country that makes two-thirds of it.

The export barrel is not the same product as the tonnage it is measured in. October 2025 shipments were 38,129.71 tonnes of product against 21,150.40 tonnes of active ingredient — 55.47 per cent active — because the mix is 95 per cent technical concentrate, 75.7 per cent water-soluble granules and 62 per cent isopropylamine salt. Almost 45 per cent of what leaves China by weight is water and salt. That is not a curiosity. It is why freight, packaging and formulation capacity are real cost lines in an export-led market, and why Chinese formulation capacity is being built alongside technical capacity rather than instead of it.

The volume and value lines have moved in opposite directions for two years running, which is the same story as the price:

• 2024: export volume +30.4 per cent, export value +3.0 per cent — an implied price fall of 21.01 per cent.
• January to July 2025: 391 kilo tons of HS 29314990, mainly glyphosate and its ammonium salt, +12 per cent year on year, above the same period of 2022.

The destinations are Brazil, the United States, Argentina, Russia and India in that order of consequence, and the demand driver is the same in all of them: transgenic soybean, maize and cotton area, where penetration in the major growing countries is already above 90 per cent. A market whose end use is 90 per cent penetrated cannot grow on adoption. It grows on acres, on the withdrawal of competing actives, and on restocking cycles — which is exactly the 2.59 per cent volume rate this report forecasts.

The intermediate layer, and the rule that keeps this report honest

Every tonne sized in this report contains 0.8123 tonnes of phosphorus trichloride. Applied to the 616.0 kilo tons China produced in 2025, that is 500.4 kilo tons of PCl₃ at stoichiometry, 46.93 per cent of Chinese PCl₃ output, or 523.6 kilo tons and 49.1 per cent at the 0.85 tonnes a tonne the industry actually consumes. The difference between those figures is the yield loss described above, and both are consistent with the chloride market sized in this segment's report on phosphorus trichloride and phosphorus oxychloride.

That arithmetic also states the netting rule. The phosphorus in this chain is counted once, at the layer where it is sold. The chloride report counts PCl₃ output including the half that never leaves the glyphosate site; this report counts the herbicide. Inside the Chinese glyphosate pool alone sit 112.9 kilo tons of contained elemental phosphorus, which are also inside the rock, the furnace and the chloride figures. Summing those reports would count the same phosphorus three and four times, and the revenue that resulted would be meaningless.

What is genuinely merchant in this layer is narrower than the title implies, and it is worth naming precisely:

• PMIDA is the one true merchant intermediate. Hebang Biotechnology runs the world’s largest diglyphosate position — 500 kilo tons a year at Guang’an — far beyond the 50 kilo tons of glyphosate it can consume itself, and is converting that capacity to glyphosate on an IDA route while building 200 to 350 kilo tons of glyphosate in Indonesia, depending on which disclosure is read.
• Dimethyl phosphite is merchant only at the margin. It is bought and sold between glycine-route producers as a balancing item and consumed captively otherwise, so there is no assessed market price an auditor would accept.
• PCl₃ merchant trade is thin for the reasons set out in the companion report: most of it is captive, and what trades is priced off yellow phosphorus rather than negotiated.

No published merchant assessment for PMIDA or dimethyl phosphite met our sourcing standard, so the intermediate layer is quantified here in tonnage and coefficient and deliberately not priced into the base. That is the conservative choice, and the omission is disclosed rather than buried: if merchant PMIDA were priced in, this market would be larger than USD 2,743.4 million, not smaller.

Where the margin sits, per tonne of phosphorus

Three reports in this segment now cover three rungs of the same ladder, and putting their margins on one denominator produces the clearest statement of what this chain rewards:

The three are not the same measure — a cash spread, a single-step conversion margin and an audited-adjacent gross profit — so the multiples should be read as orders of magnitude rather than as an index. The order of magnitude is the finding: a tonne of contained phosphorus earns 18.4 times more as glyphosate than as phosphorus trichloride. And the direction is counter-intuitive in exactly one respect. The product with the lowest phosphorus content earns the most per tonne of phosphorus, because what the customer buys is not the phosphorus — it is the chemistry that made it selective in a soybean field. PCl₃ is 22.55 per cent phosphorus and sells the phosphorus. Glyphosate is 18.32 per cent phosphorus and sells a registration, a mode of action and a formulation.

That is the structural argument for the shape of this cluster: rock, furnace and chloride are one business, priced on contained phosphorus and on electricity; the derivative is another, priced on chemistry and on intellectual property. The bridge between them is a fixed coefficient — 0.1832 tonnes of P₄ per tonne of glyphosate — that nobody on either side can negotiate.

Forecast 2026 to 2033

The forecast is built from capacity, not from demand, because capacity is the variable the state controls. World nameplate is held at 1,178 kilo tons throughout: new glyphosate plants sit in the restricted category of China’s 2024 industrial structural adjustment catalogue, and the two announced projects — a 100 kilo ton Jiangshan and Wengfu joint venture and Hebang’s Indonesian capacity — are excluded from the base path and treated as upside risk in the regulatory chapter. Utilisation recovers from 76.04 per cent in 2025 to 93.28 per cent in 2033, which is 203.1 kilo tons of additional output from zero new furnaces, zero new chlorination trains and zero new permits.

Price is modelled separately and more conservatively. The 2025 average of USD 3,062.8 was a trough year in which the industry spent the second half within a few hundred renminbi of its cash floor; 2026 is given a single 4.63 per cent recovery to RMB 26,000, then 2.40 per cent a year — enough to hold real margin against input inflation, not enough to invite the capacity the catalogue forbids.

Value grows 5.33 per cent a year and volume 2.59 per cent — a ratio of roughly two to one, and the same ratio the segment’s other reports produce: thermal phosphoric acid at 5.83 against 3.21, phosphorus trichloride at 6.45 against 2.26. The consistency is not a template applied to three markets. It is the same physical fact in each: a capacity-constrained intermediate chain in a regulated economy grows its revenue through utilisation and price, never through tonnage.

What would move the number most is not demand. It is the 370 kilo tons of capacity — 31.4 per cent of the world — held by Bayer through the former Monsanto business and subject to litigation that had, by May 2025, produced reports of a settlement process and of a possible bankruptcy filing for the subsidiary. That scenario is quantified in the market risk chapter, and it is the only variable here large enough to invalidate the forecast.

Assumptions and limitations

Five assumptions carry this report, and each is stated so it can be argued with:

1. Chinese output of 616.0 kilo tons. Annualised from first-half 2025 production of 308.0 kilo tons, which was 0.9 per cent below the prior year at a 76 per cent annualised operating rate. Cross-check: 810 kilo tons of capacity at 76 per cent is 615.6 kilo tons. The two routes agree to within 0.4 kilo tons.
2. Non-Chinese output at the same 76 per cent. Bayer does not disclose a glyphosate operating rate, so the observed Chinese rate is applied to the 368 kilo tons of non-Chinese capacity: 279.7 kilo tons. This is the least-supported input in the model. At 90 per cent, non-Chinese output would be 331.2 kilo tons and the global base 947.2 kilo tons, 5.75 per cent higher, and every figure here scales with it.
3. One valuation price for all tonnes. Chinese and non-Chinese material are both valued at the de-VATed Chinese technical realisation. Bayer’s product is sold as branded formulation at several times technical, and that brand and retail layer sits outside this perimeter by construction. The market sized here is the active-ingredient market.
4. Capacity fixed at 1,178 kilo tons to 2033. Announced projects are excluded. If they build, volume grows faster and price grows slower while the value line is broadly unchanged: the volume is additive to supply, not to the market.
5. Merchant intermediates excluded from value. PMIDA and dimethyl phosphite are quantified in tonnage and coefficient and not priced in, because no merchant assessment met our sourcing standard. This understates the market rather than overstating it.

Figures are not adjusted for the possibility that 2025 export growth was partly restocking rather than consumption. Export volume rose 12 per cent in seven months against a domestic market that was shrinking, which is consistent with either.

Table of Contents

• The herbicide priced by its weaker route
• A tonne of glyphosate, priced from its own cost sheet
• Two routes, one phosphorus atom
• Fifty-five per cent of world tonnage crosses a border
• The intermediate layer, and the netting rule
• Where the margin sits, per tonne of phosphorus
• Forecast 2026 to 2033
• Assumptions and limitations
• Value chain
• Technology and innovation
• Competitive landscape
• Investment activity
• Market risk
• Regulatory landscape

Competitive Landscape

Four companies hold seventy per cent of the world

World glyphosate nameplate is 1,178 kilo tons and the top four hold 833 of it, 70.7 per cent. The distribution is unusually clean for a commodity: Bayer 370 to 380 kilo tons, Hubei Xingfa 230, Fuhua Chemical 153, Zhejiang Wynca 80, Nantong Jiangshan 70, Hebang Biotechnology 50, Jiangsu Yangnong 30 and Guangxin 20, with the balance spread across the eighteen Chinese sites that still operate. CR4 capacity is 833 kilo tons, and on a global basis that is 70.7 per cent.

Concentration is a policy outcome, not a market one

Environmental verification rounds in 2013 to 2015, supply-side reform in 2016 and the “three phosphorus” remediation campaign in 2019 removed the marginal Chinese producer and left eighteen operating sites out of a much larger historic population. Since 2018 almost no greenfield capacity has been added anywhere in the world, and the 2024 catalogue made that structural rather than cyclical. The consequence for competitive behaviour is that nobody in this market can respond to price with volume, which is precisely why the industry can hold an anti-involution consensus at all.

What the filings say about profitability

Xingfa reported 2025 revenue of RMB 29,299.5 million, up 3.18 per cent, and net profit attributable to shareholders of RMB 1,492.1 million, down 6.83 per cent; glyphosate and its formulations are more than 90 per cent of its pesticide revenue, and it holds the number one position in China at 230 kilo tons with 117 kilo tons of formulation capacity behind it. Yangnong reported revenue of RMB 11,870.4 million, up 13.76 per cent, and net profit of RMB 1,286.0 million, up 6.98 per cent, on technical output of 113.8 kilo tons across about 70 actives — with an explicit price loss of RMB 278 million on technical products, which is what a 30 kilo ton glyphosate position inside a diversified portfolio looks like. Both companies made more money in 2025 than in 2024 on volumes that grew faster than prices, which is the utilisation story told in financial statements.

The one name that cannot be priced

Bayer’s position is the reason this market has a risk chapter at all. It is 31.4 per cent of world capacity, it sits inside a litigation process that in May 2025 was reported to involve both settlement discussions and a possible bankruptcy filing for the Monsanto subsidiary, and it is the only capacity in the world whose continuation is a legal question rather than an economic one. No competitor can build a replacement: the catalogue forbids it in China, and nobody has built greenfield glyphosate elsewhere since 2018.

Value Chain

It begins at a chlor-alkali plant

Glyphosate is a phosphorus molecule, but the chain does not start at a mine. The glycine route consumes about one tonne of chlorine per tonne of product, and chlorine is a co-product that cannot be stored and cannot be turned down independently of caustic soda. In the second quarter of 2025 liquid chlorine in Jiangsu averaged minus RMB 179 a tonne; a glyphosate train is therefore, in part, a chlorine sink that pays back in a saleable molecule. The same negative assessment is what makes the companion chloride report’s margin arithmetic work, and it is why the integrated phosphorus producers with chlor-alkali neighbours have a cost position nobody else can replicate.

Phosphorus in the middle, and it is the whole input

Yellow phosphorus is made in submerged-arc furnaces at roughly 13,000 kilowatt-hours per tonne of P4, concentrated in Yunnan, Sichuan, Guizhou and Hubei. One tonne of glyphosate contains 0.1832 tonnes of P4, which at 0.8123 tonnes of PCl₃ and 2,932 kilowatt-hours per tonne of chloride is about 2,381.7 kilowatt-hours of embedded electricity. That is the number that ties this report back to the thermal phosphoric acid market: the furnace, not the reactor, is where this chain’s energy and emissions sit, and a phosphorus permit is a glyphosate permit.

The loops are the moat

Both routes throw off hydrogen chloride, and how a site handles it decides whether the site is viable. Dimethyl phosphite synthesis releases two moles of HCl per mole of phosphite; the glyphosate condensation releases two moles of methanol that are recovered and returned to phosphite synthesis. At Xingfa the loops extend across businesses: chloromethane recovered from glyphosate synthesis feeds the silicone operation, and hydrochloric acid returning from silicone goes back into glyphosate. A stand-alone plant without an HCl outlet and without methanol recovery carries two waste costs its integrated competitor does not have, which is the real reason Chinese capacity concentrated into six groups rather than staying with the eighteen sites that nominally exist.

Where the chain ends

Technical glyphosate leaves the plant as acid or as a salt — isopropylamine, monoammonium, potassium, sodium — and the export mix shows how much of the value is created after the technical step: only 55.47 per cent of October 2025 export tonnage was active ingredient. Formulation, adjuvant systems, drift control and registration are the last two steps, and they are where the margin that the Chinese technical producers do not earn is captured. This report stops at the technical/active-ingredient boundary deliberately; the branded formulation market is a different business with a different cost structure and a different set of owners.

Investment Activity

Nobody is building the molecule

Capital in this chain goes into integration and into the step after the technical product, not into new glyphosate trains. Xingfa’s committed spend is upstream and adjacent: a 53 kilo ton yellow phosphorus technical upgrade at Yuan’an, 585 kilo tons a year of phosphate rock capacity already owned, thermal phosphoric acid going from 150 to 225 kilo tons a year at over 70 per cent utilisation, and a 35 kilo ton phosphorus flame retardant project at Xinghua. Every one of those investments makes the glyphosate position cheaper or gives the phosphorus a second exit; none of them adds herbicide capacity.

Hebang is the exception, and it is a conversion not an addition

The largest single commitment in the market is Hebang’s decision to convert 500 kilo tons of Guang’an diglyphosate capacity to a glyphosate-capable IDA route, alongside a reported 200 to 350 kilo tons of Indonesian glyphosate capacity, the figure varying between the sell-side compilation and the trade press. Both are the acts of a company that already owns the intermediate: if you make half a million tonnes of PMIDA and can only consume 50 kilo tons of it, the marginal return on an oxidation train is high and the marginal return on a new technical plant is not.

What gets built is formulation

Chinese producers are adding salt and granule capacity at the same time as they add nothing upstream, because 44.5 per cent of export weight is currently water and salt moving across an ocean. This is the highest-return capital in the chain: it converts technical tonnage into a registered product at a fraction of the cost of a technical train, and it captures the part of the value the technical producer currently gives away to the formulator.

There is no M&A, and there will not be

No transaction of consequence has occurred in this market in years. The assets worth owning are inside integrated groups for which glyphosate is a cost centre rather than a business, and what is available is stand-alone capacity in a segment that cannot be expanded — which caps the multiple any buyer can justify. Consolidation in the chain happens one step down, in branded formulation and distribution, where registrations can be bought and grown.

Technology & Innovation

The molecule is off patent and the innovation is in the process

Glyphosate has been generic for a quarter of a century, and no new chemistry has displaced it. What has changed is the yield on the steps that already exist. The PMIDA oxidation is the clearest case: chemistry requires 1.3433 tonnes of diglyphosate per tonne of glyphosate, the industry consumes about 1.5, and the 10 per cent between them — an implied yield of 89.55 per cent — is the target of essentially every process patent filed in this market. The phosphorus is already bought and chlorinated by the time that loss occurs, so a percentage point of yield is worth more than a percentage point of any input price.

Two routes, and the choice is strategic rather than technical

The glycine route dominates China at roughly two-thirds of national capacity because glycine is domestically available and the phosphite intermediate is shared with the wider organophosphorus sector. The IDA route dominates the West because hydrogen cyanide and diethanolamine sit inside existing chemical clusters — and because the PMIDA oxidation is a cleaner single step. Neither is measurably cheaper at 2025 prices: the spread data show the glycine route at RMB 3,000 gross profit per tonne in August, which is thin enough that route economics are decided by integration and by the price of one purchased intermediate rather than by the chemistry.

What is actually being built

The engineering effort has moved to two places. The first is capacity conversion: Hebang is converting 500 kilo tons of Guang’an diglyphosate to a glyphosate-capable IDA route, which is a chemistry change inside an existing asset rather than a new plant. The second is formulation and application technology, where Chinese producers are building out salt and granule capacity to capture the 44.5 per cent of export weight that is currently water and salt, and where drift-reduction and adjuvant systems are the only patentable surface left on the product.

The substitution threat is real but priced

Glufosinate clears at a substantial premium to glyphosate — RMB 47,000 a tonne in August 2025 against glyphosate’s RMB 27,300 — and dicamba and 2,4-D systems absorb some trait-driven demand. None of them has the cost position, and none can be applied with the same flexibility. Substitution is therefore modelled as a slow share drift inside the volume path rather than as a discontinuity, and the observed outcome of a decade of attempted substitution is that glyphosate remains the largest herbicide in the world.

Market Risk

1. The 370 kilo tons that are a legal question

This is the largest risk in the report and it is not a judgement call. Bayer holds 370 to 380 kilo tons, 31.4 per cent of world capacity, and through 2025 it faced reported settlement negotiations over the Roundup litigation alongside reports that it might seek bankruptcy for the Monsanto subsidiary. Remove 370 kilo tons and world capacity is 808 kilo tons against 895.7 kilo tons of demand: a shortfall of 87.7 kilo tons, 9.79 per cent of world consumption, that no operating rate can close. The last time this market cleared a physical shortage, in 2021 and early 2022, glyphosate technical traded at multiples of today’s price. Every number in this forecast is conditional on Bayer continuing to produce.

2. The price is already at the cash floor

At December 2025’s RMB 23,700 the glycine route was within about RMB 750 of earning nothing after depreciation and labour. That is not a comfortable place for a market to sit, and the direction of the error is asymmetric: the anti-involution consensus that held prices up through 2025 is an agreement, not a mechanism, and it can fail. If Chinese utilisation instead of recovering stays at 76 per cent while the 100 kilo ton Jiangshan project and Hebang’s conversion both land, volume rises and value does not — the exact inverse of this report’s forecast, and the reason the value rate is 5.33 per cent rather than the 7 per cent a simple utilisation recovery would support.

3. The export channel is the market, and it is discretionary

55.02 per cent of world tonnage leaves China. Anything that interrupts that flow — a destination-market registration failure, a Brazilian or Argentine harvest reversal, a Chinese export control, a freight event, or a bilateral trade action — lands directly on a market whose domestic Chinese consumption is only 13.75 per cent of global tonnage and therefore cannot absorb the difference. The 2024 evidence of how thin this is: export volume up 30.4 per cent, export value up 3.0 per cent.

4. Regulation cuts both ways, and the purity bar is rising

The EU’s 2023 renewal of glyphosate approval came with conditions and restrictions that raise the purity specification, including limits on nitrosamine precursors, which favours integrated producers with modern effluent and distillation capability and penalises marginal ones. The commercial risk is not prohibition — no major jurisdiction has banned the active — it is a specification step change that strands capacity built to an older standard.

5. Substitution and resistance

Resistance in key weeds is a slow structural tax on application rates, and glufosinate, dicamba and 2,4-D trait systems take share where trait stacks permit. Glufosinate at RMB 47,000 a tonne against glyphosate’s RMB 27,300 is a price umbrella that protects glyphosate demand rather than threatening it. The risk that matters is not a substitute molecule; it is a trait event in the United States or Brazil that changes the recommended programme on a large acreage.

6. Restocking is not consumption

2025 export growth of 12 per cent in seven months occurred against a shrinking domestic market and a price that rose 24 per cent and then gave it all back. Some of that was distributors refilling after two years of destocking. If it was more restocking than consumption, the 2026 volume line is 2 to 3 per cent too high.

Regulatory Landscape

China: the permit is the market

The regulation that sets this market’s size is not environmental, it is industrial. The National Development and Reform Commission’s Industrial Structural Adjustment Guidance Catalogue, 2024 edition, lists new glyphosate production plants as a restricted project type, which is the formal instrument behind the observed absence of greenfield capacity since 2018. Alongside it sit the hazardous chemicals regime, a dedicated production licence, the “three phosphorus” effluent standards that removed the marginal producer in 2019, and the equal-or-reduce replacement rule on yellow phosphorus that caps the input at 1.58 million tonnes. In this market, a phosphorus permit is a glyphosate permit, and neither is obtainable.

The anti-involution consensus

On 13 March 2025 the industry convened a dedicated meeting in Beijing on “involution” — destructive competition — following the broader policy language of the two sessions. Producers subsequently cut rates and held offers, which is the proximate cause of the 24 per cent price recovery from the May low. This is a consensus, not a regulation: it has no statutory force, it binds only the participants who choose to be bound, and its durability is the single largest determinant of the 2026 price line in this report.

Europe: renewal with conditions

The European Union renewed glyphosate approval in 2023 with conditions and restrictions, including purity and impurity limits that raise the specification bar for material sold into Europe. The practical effect on a Chinese exporter is that the highest-purity fraction earns the access and the rest is redirected to less demanding destinations — a segmentation of value inside a single product name that the export mix data already show.

Standards and the FAO specification

Xingfa’s Taisheng subsidiary holds the distinction of having authored the FAO specification for glyphosate technical, 284/TC, the first Chinese company to have an international standard of this kind adopted. That matters commercially rather than symbolically: whoever writes the specification defines the impurity profile the market is tested against, and an integrated producer with modern purification is the natural author of a tighter one.

What is not regulated

Glyphosate is not a Chemical Weapons Convention scheduled chemical, unlike the phosphorus trichloride one step upstream, so its export channel does not carry the declaration and end-use friction that constrains the chloride trade. It is a conventional agricultural chemical with a registration regime in every destination market — which means the binding constraint on Chinese exports is registration in Brazil, the United States, Argentina and India, not Chinese export law.